AstraZeneca PLC Ordinary Shares (AZN)

Stockholders Equity

$50.24B

Quarterly · Period ending: · USD

AZN logo

AZN Stockholders Equity

Latest reported$50.24B
AZN Quarterly Shareholders Equity ($2.22B → $50.24B)
High-resolution chart · PNG

AZN stockholders equity history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Stockholders Equity — Quarterly (USD)
Period endingStockholders Equity (USD)
50,236,264,000
47,333,000,000
48,667,000,000
45,888,000,000
44,719,000,000
41,039,000,000
40,786,000,000
40,719,000,000
39,512,000,000
37,445,000,000
39,143,000,000
37,197,000,000
37,392,000,000
35,789,000,000
37,037,000,000
35,134,000,000
35,932,000,000
36,340,000,000
39,268,000,000
39,744,000,000
15,676,000,000
14,430,000,000
15,622,000,000
12,195,000,000
12,237,000,000
10,778,000,000
13,127,000,000
12,164,000,000
13,548,000,000
10,483,000,000
12,468,000,000
11,936,000,000
12,645,000,000
12,915,000,000
14,960,000,000
13,725,000,000
13,653,000,000
12,989,000,000
14,854,000,000
13,072,000,000
13,530,000,000
14,741,000,000
18,490,000,000
17,349,000,000
18,279,000,000
16,936,000,000
19,627,000,000
20,445,000,000
22,029,000,000
21,454,000,000
23,224,000,000
23,248,000,000
23,216,000,000
22,292,000,000
23,737,000,000
22,038,000,000
22,026,000,000
21,516,000,000
23,246,000,000
23,931,000,000
23,606,000,000
22,349,000,000
23,213,000,000
22,125,000,000
22,091,000,000
20,727,000,000
20,660,000,000
19,394,000,000
17,796,000,000
15,383,000,000
15,912,000,000
16,105,000,000
15,974,000,000
14,720,000,000
14,778,000,000
14,614,000,000
14,847,000,000
13,907,000,000
15,304,000,000
14,683,000,000
14,910,000,000
15,304,000,000
13,597,000,000
13,275,000,000
13,477,000,000
13,597,000,000
14,418,000,000
13,332,000,000
12,707,000,000
12,319,000,000
13,178,000,000
13,565,000,000
12,731,378,779
12,174,035,371
11,172,000,000
11,551,560,529
11,056,676,140
10,494,246,776
13,710,935,239
9,991,425,525
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.